日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
TIS and Towa Pharma Unveil Digital Healthcare Passport
TIS Inc., a member of the TIS INTEC Group, and Towa Pharmaceutical…
Medical AI “Ubee” Launches to Reduce Patient Confusion
Ubie Inc., whose mission is to "guide people to appropriate medical care…
Smart Pills and Ingestible Sensors: The Next Wave in Internal Health Tracking
For the past decade, the frontier of health technology has been worn…
medicalforce Launches Automatic Message Delivery Tool
Medical Force Co., Ltd., which provides the business management system "medicalforce" for…
Stranza and AI Shift Update Denwa Garakuda AI Service
Stranza Inc., developer of the cloud-based business management system "Apotool & Box"…
Rohto Pharma Builds Global Platform with Dynamics 365
Hitachi Solutions, Ltd. has implemented Microsoft Dynamics 365 at Rohto Pharmaceutical Co.,…
Ichiro Co., Ltd. Raises ¥1.13B in Series B Funding
Ichiro Co., Ltd., operator of the custom-tailored nursing care service "Ichiro," has…
Digital Therapeutics in Japan: How AI Is Rewriting the Future of Mental Health Care
For years, Japan's corporate world has quietly talked about mental health. Stigma…
Latest Article
English